Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$112.02NASDAQ Closing Price as of 4:00PM ET 9/24/20

Today's Change-0.41(0.36%)
Bid (Size)$108.02 (1)
Ask (Size)$117.00 (1)
Day Low / High$110.41 - 113.60
Volume1.3 M

View Biotechnology IndustryPeer Comparison as of 09/24/2020


Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $112.02
Change: -0.41 (0.36%)
Volume: 1.3 M
4:00PM ET 9/24/2020

Moderna Inc ( NASDAQ )

Price: $65.17
Change: -1.99 (2.96%)
Volume: 5.6 M
4:00PM ET 9/24/2020

Immunomedics Inc ( NASDAQ )

Price: $85.30
Change: +0.13 (0.15%)
Volume: 5.3 M
4:00PM ET 9/24/2020

Incyte Corp ( NASDAQ )

Price: $85.07
Change: -0.90 (1.05%)
Volume: 1.0 M
4:00PM ET 9/24/2020

Seattle Genetics Inc ( NASDAQ )

Price: $179.43
Change: +0.16 (0.09%)
Volume: 780.8 K
4:00PM ET 9/24/2020

Read more news Recent News

European Regulator Recommends Approval of Alexion's New Advanced Formulation of Ultomiris
6:31AM ET 9/21/2020 MT Newswires

Alexion Pharmaceuticals (ALXN) said premarket Monday a European Medicines Agency committee is recommending European Union marketing authorization of an...

Alexion Pharmaceuticals, Fortress Biotech Unit Commence Phase 3 Studies of Amyloidosis Treatment
10:21AM ET 9/14/2020 MT Newswires

Alexion Pharmaceuticals (ALXN) and Fortress Biotech (FBIO) unit Caelum Biosciences said Monday they have initiated enrollment for the phase 3 trials of the...

--Analyst Actions: Stifel Starts Alexion Pharmaceuticals at Hold With $117 Price Target
9:35AM ET 9/01/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

2020 and 2021 Estimates for Alexion Pharmaceuticals Targeted Higher but Q3 Earnings Number Reduced
11:50PM ET 7/31/2020 MT Newswires

Alexion Pharmaceuticals Inc's (NASDAQ:ALXN, Recent Price: 102.49) forecasted earnings estimates for Q3 ending September 30, 2020, and the full year...

View all Commentary and Analysis

XLV: Healthcare Dashboard For September
10:11AM ET 9/16/2020 Seeking Alpha

Wall Street Breakfast: The Week Ahead
6:41AM ET 9/13/2020 Seeking Alpha

Stocks To Watch: Apple, Snowflake, Pfizer And Moderna In Focus
8:40AM ET 9/12/2020 Seeking Alpha

Why Stocks Could Be Ready To Rally
8:58AM ET 9/11/2020 Seeking Alpha

Company Profile

Business DescriptionAlexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. View company web site for more details
Address121 Seaport Boulevard
Boston, Massachusetts 02210
Number of Employees2,656
Recent SEC Filing08/25/20208-K
Chief Executive Officer & DirectorLudwig N. Hantson
President & DirectorAradhana Sarin
Chief Commercial, Global Operations Officer & EVPBrian M. Goff
Executive VP, Head-Research & DevelopmentJohn J. Orloff

Company Highlights

Price Open$112.02
Previous Close$112.43
52 Week Range$72.67 - 121.50
Market Capitalization$24.6 B
Shares Outstanding219.2 M
SectorHealth Technology
Next Earnings Announcement10/28/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings30.41
Earnings per Share$10.41
Beta vs. S&P 500N/A
Revenue$4.1 B
Net Profit Margin15.40%
Return on Equity7.71%

Analyst Ratings as of 09/17/2020

Consensus RecommendationConsensus Icon
Powered by Factset